null Option on Guardant Health

GH Stock  USD 45.83  0.19  0.42%   
Guardant Health's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 0.64 with a put-to-call open interest ratio of 2.18 over 44 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on October 17th 2025. The total put volume is at 21.0, with calls trading at the volume of 18.0. This yields a 1.17 put-to-call volume ratio.

Open Interest Against October 17th 2025 Option Contracts

The chart above shows Guardant Health's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Guardant Health's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Guardant Health's option, there is no secondary market available for investors to trade.

Guardant Health Maximum Pain Price Across 2025-10-17 Option Contracts

Guardant Health's max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Guardant Health

Analyzing Guardant Health's in-the-money options over time can help investors to take a profitable long position in Guardant Health regardless of its overall volatility. This is especially true when Guardant Health's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Guardant Health's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Guardant Health's stock while costing only a fraction of its price.

Guardant Health In The Money Call Balance

When Guardant Health's strike price is surpassing the current stock price, the option contract against Guardant Health stock is said to be in the money. When it comes to buying Guardant Health's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Guardant Health are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Guardant Current Options Market Mood

Guardant Health's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Guardant Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Guardant Health's options investors are not very successful. Guardant Health's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Guardant contract

Base on the Rule 16, the options market is currently suggesting that Guardant Health will have an average daily up or down price movement of about 0.04% per day over the life of the 2025-10-17 option contract. With Guardant Health trading at USD 45.83, that is roughly USD 0.0183. If you think that the market is fully incorporating Guardant Health's daily price movement you should consider buying Guardant Health options at the current volatility level of 0.64%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Guardant Health options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Guardant calls. Remember, the seller must deliver Guardant Health stock to the call owner when a call is exercised.

Guardant Health Option Chain

When Guardant Health's strike price is surpassing the current stock price, the option contract against Guardant Health stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Guardant Health's option chain is a display of a range of information that helps investors for ways to trade options on Guardant. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Guardant. It also shows strike prices and maturity days for a Guardant Health against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
GH251017C00075000075.00.0 - 0.70.7Out
Call
GH251017C000700006970.00.0 - 2.551.7Out
Call
GH251017C000650002265.00.45 - 1.21.3Out
Call
GH251017C0006000014860.00.0 - 2.31.55Out
Call
GH251017C000550008055.02.1 - 2.452.5Out
Call
GH251017C00050000116050.03.5 - 3.94.0Out
Call
GH251017C000490007749.03.9 - 4.24.5Out
Call
GH251017C000480001948.04.2 - 5.16.39Out
Call
GH251017C000470001947.04.3 - 5.88.7Out
Call
GH251017C000460006446.03.6 - 7.37.8Out
Call
GH251017C00045000445.04.5 - 7.88.6In
Call
GH251017C000440001144.04.6 - 7.28.0In
Call
GH251017C00042000342.06.8 - 7.912.2In
Call
GH251017C00041000741.07.5 - 9.37.5In
Call
GH251017C000400002940.08.2 - 9.512.9In
Call
GH251017C000390005439.08.8 - 10.513.32In
Call
GH251017C00037000737.09.4 - 13.07.7In
Call
GH251017C000360003336.09.6 - 13.616.9In
Call
GH251017C000350004335.010.4 - 14.416.95In
Call
GH251017C00030000330.014.8 - 18.722.35In
Call
GH251017C00025000125.019.2 - 23.219.2In
 Put
GH251017P00025000125.00.0 - 1.51.0Out
 Put
GH251017P00030000430.00.0 - 1.21.0Out
 Put
GH251017P000350008135.00.85 - 2.70.99Out
 Put
GH251017P00036000236.00.0 - 3.42.6Out
 Put
GH251017P000370002837.01.3 - 3.63.1Out
 Put
GH251017P000380001138.00.05 - 3.91.97Out
 Put
GH251017P00039000239.00.55 - 3.12.25Out
 Put
GH251017P000400003740.02.25 - 2.852.49Out
 Put
GH251017P000410001841.02.45 - 3.42.82Out
 Put
GH251017P000420006342.03.0 - 4.52.62Out
 Put
GH251017P000430002443.01.7 - 4.67.2Out
 Put
GH251017P000440002044.02.3 - 6.03.7Out
 Put
GH251017P00045000371045.04.0 - 5.53.7Out
 Put
GH251017P00046000146.04.7 - 7.04.7In
 Put
GH251017P00047000447.03.6 - 6.64.6In
 Put
GH251017P000480001248.05.8 - 7.25.8In
 Put
GH251017P00049000349.06.3 - 7.87.9In
 Put
GH251017P000500001250.07.0 - 8.55.9In
 Put
GH251017P00055000955.09.6 - 12.210.0In
 Put
GH251017P00060000060.013.2 - 16.913.2In
 Put
GH251017P00065000065.017.7 - 21.517.7In
 Put
GH251017P00070000070.022.4 - 26.022.4In
 Put
GH251017P00075000075.027.3 - 31.427.3In

Guardant Health Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Guardant Total Stockholder Equity

Total Stockholder Equity

(132.66 Million)

As of now, Guardant Health's Total Stockholder Equity is increasing as compared to previous years.

Guardant Health Corporate Management

Jennifer HigginsSenior AffairsProfile
Stephen MurphySenior MarketingProfile
Gulshan JDSenior OfficerProfile
John SaiaChief SecretaryProfile
Christopher FreemanChief OncologyProfile
John JDChief SecretaryProfile
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.39)
Revenue Per Share
6.278
Quarterly Revenue Growth
0.208
Return On Assets
(0.19)
Return On Equity
(45.84)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.